ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies

ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies

PHOENIX, June 25 -- ThirdBiotech Inc., (http://www.thirdbiotech.com), a biotechnology incubator and life sciences association, today announced that it has launched the ThirdBiotech Research Group including a drug discovery research institute and technology incubator for the promotion of collaborative activities between researchers and industry for the formation of biotechnology companies in Arizona.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/LATU119LOGO)

"Over the past year, we've successfully established ThirdBiotech as an organization for bringing together Arizona biotech companies, groups and life science industry individuals to meet in a relaxed setting outside of the work place and form relationships that can provide a basis for future professional collaborative efforts," said Jeff Morhet, CEO of InNexus Biotechnology and Founder of ThirdBiotech. Morhet continued, "Today, I am pleased to announce the expansion of ThirdBiotech to include the ThirdBiotech Research Group. The Group's mission is to form and establish biotech companies based in Arizona by working with collaborative partners, researchers and investors. It has already developed the ThirdBiotech Virtual Incubator, making low-cost or donor resources available for budding scientists and early stage technologies before large investments and fixed resources are required or committed."

ThirdBiotech's innovative and best-practices mentality, whose motto is "For Progress - Not For Profit(TM)", is providing early technology and researchers a novel, accessible and inventive pathway to develop their discoveries into biotechnology companies creating medicines.

About ThirdBiotech

ThirdBiotech, created to foster networking and collaboration for the biotech, life sciences and healthcare community, provides research resources and drug development expertise for early technology companies while assembling a pathway for researchers to develop and fund themselves into biotechnology companies committed to developing products and creating value.

Around every third week of the month, ThirdBiotech also invites people from the Arizona Biotechnology community to trendy spots in Tucson, Phoenix and Scottsdale. The event, which features no lectures, just fun is attended by a variety of industry professionals, including entrepreneurs, investors, attorneys, scientists and journalists.

For more information about ThirdBiotech or the ThirdBiotech Research Group and how the group is bridging together the life science industry, visit us on the web at http://www.thirdbiotech.com.

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

The data position Leo to file for approval of the Dupixent rival in atopic dermatitis next year.